PIK3CA and cervical cancer: In gynecologic malignancies, phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) mutations are found in 23%, 10% and 12% of endometrial, ovarian, and cervical cancers, respectively[42].